Govindan R - Search Results

1

A phase I study of docetaxel and bexarotene.

Wildi JD, Baggstrom MQ, Suresh R, Read W, Fracasso PM, Govindan R. Wildi JD, et al. Among authors: govindan r. Chemotherapy. 2008;54(2):125-30. doi: 10.1159/000119706. Epub 2008 Mar 7. Chemotherapy. 2008. PMID: 18332628 Clinical Trial.

2

Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.

Fracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL. Fracasso PM, et al. Among authors: govindan r. Ann Oncol. 2002 Nov;13(11):1819-25. doi: 10.1093/annonc/mdf342. Ann Oncol. 2002. PMID: 12419757 Free article. Clinical Trial.

3

Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.

Fracasso PM, Rodriguez LC, Herzog TJ, Fears CL, Goodner SA, Govindan R, Picus J, Rader JS, Tan BR, Arquette MA. Fracasso PM, et al. Among authors: govindan r. Cancer. 2003 Aug 1;98(3):610-7. doi: 10.1002/cncr.11547. Cancer. 2003. PMID: 12879480 Free article. Clinical Trial.

4

Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancer.

Govindan R, Read W, Faust J, Mc Leod H. Govindan R, et al. Oncology (Williston Park). 2003 Jul;17(7 Suppl 7):27-9. Oncology (Williston Park). 2003. PMID: 12886871 Clinical Trial.

5

Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report.

Govindan R, Read W, Faust J, Trinkaus K, Ma MK, Baker SD, McLeod HL, Perry MC. Govindan R, et al. Oncology (Williston Park). 2003 Sep;17(9 Suppl 8):27-31. Oncology (Williston Park). 2003. PMID: 14569845 Free article. Clinical Trial.

6

Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC.

Rocha Lima CM, Rizvi NA, Zhang C, Herndon JE 2nd, Crawford J, Govindan R, King GW, Green MR; Cancer Leukemia Group B. Rocha Lima CM, et al. Among authors: govindan r. Ann Oncol. 2004 Mar;15(3):410-8. doi: 10.1093/annonc/mdh104. Ann Oncol. 2004. PMID: 14998842 Free article. Review.

7

The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database.

Read WL, Page NC, Tierney RM, Piccirillo JF, Govindan R. Read WL, et al. Among authors: govindan r. Lung Cancer. 2004 Aug;45(2):137-42. doi: 10.1016/j.lungcan.2004.01.019. Lung Cancer. 2004. PMID: 15246183

8

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R. Kommareddy A, et al. Among authors: govindan r. Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022. Lung Cancer. 2004. PMID: 15246194

9

Differential prognostic impact of comorbidity.

Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF. Read WL, et al. Among authors: govindan r. J Clin Oncol. 2004 Aug 1;22(15):3099-103. doi: 10.1200/JCO.2004.08.040. J Clin Oncol. 2004. PMID: 15284260

10

Irinotecan and carboplatin in metastatic or recurrent NSCLC: an update.

Read W, McLeod H, Govindan R. Read W, et al. Among authors: govindan r. Oncology (Williston Park). 2004 Dec;18(14 Suppl 14):15-7. Oncology (Williston Park). 2004. PMID: 15685828 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

652 results

Search Page

Filters